Therefore, the present study aims to investigate the frequency of EGFR and KRAS mutations in a large Brazilian series of lung adenocarcinoma, and to correlate the presence of these mutations with patients’ genetic ancestry and clinicopathological and sociodemographic characteristics. Here, KRAS is linked to lung adenocarcinoma.